A Phase I Dose-Escalation Study of Cisplatin and Radiation Therapy for Patients With Triple Negative Breast Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 25 Aug 2021 Biomarkers information updated
- 09 Oct 2012 Planned End Date changed from 1 Oct 2014 to 1 Oct 2017 as reported by ClinicalTrials.gov.
- 01 Oct 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.